BRPI0908309A2 - "método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3" - Google Patents

"método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3"

Info

Publication number
BRPI0908309A2
BRPI0908309A2 BRPI0908309-0A BRPI0908309A BRPI0908309A2 BR PI0908309 A2 BRPI0908309 A2 BR PI0908309A2 BR PI0908309 A BRPI0908309 A BR PI0908309A BR PI0908309 A2 BRPI0908309 A2 BR PI0908309A2
Authority
BR
Brazil
Prior art keywords
carboxylesterase
genes
vitro
proteins
vivo method
Prior art date
Application number
BRPI0908309-0A
Other languages
English (en)
Inventor
Michel Rivier
ANDRé JOMARD
Séverine Corvaisier
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0908309A2 publication Critical patent/BRPI0908309A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/20Dermatological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/20Dermatological disorders
    • G01N2800/202Dermatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0908309-0A 2008-05-07 2009-05-07 "método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3" BRPI0908309A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7159308P 2008-05-07 2008-05-07
FR0857715A FR2938342A1 (fr) 2008-11-13 2008-11-13 Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
PCT/EP2009/055561 WO2009135916A1 (en) 2008-05-07 2009-05-07 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea

Publications (1)

Publication Number Publication Date
BRPI0908309A2 true BRPI0908309A2 (pt) 2015-08-18

Family

ID=40790878

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908309-0A BRPI0908309A2 (pt) 2008-05-07 2009-05-07 "método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3"

Country Status (9)

Country Link
US (1) US20110150774A1 (pt)
EP (1) EP2283158A1 (pt)
JP (1) JP2011519572A (pt)
BR (1) BRPI0908309A2 (pt)
CA (1) CA2723838A1 (pt)
FR (1) FR2938342A1 (pt)
MX (1) MX2010011729A (pt)
RU (1) RU2010150112A (pt)
WO (1) WO2009135916A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111406113B (zh) * 2017-11-30 2024-04-16 花王株式会社 评价或选择感觉刺激降低剂的方法
JP6621796B2 (ja) * 2017-11-30 2019-12-18 花王株式会社 感覚刺激低減剤の評価又は選択方法
WO2021092440A1 (en) * 2019-11-07 2021-05-14 Icahn School Of Medicine At Mount Sinai Synthetic modified rna and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4233297A (en) * 1996-08-23 1998-03-06 Arch Development Corporation Identification of activators and inhibitors of sebum formation
YU57502A (sh) * 2000-02-02 2006-01-16 Warner-Lambert Company Dvojni inhibitori sinteze estara holesterola i estara voska kod poremećaja lojne žlezde
JP2007508291A (ja) * 2003-10-09 2007-04-05 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 皮脂産生を減少させるためのマロンアミド誘導体を含んでなる医薬組成物
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2904004B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de scarb-1 dans le traitement de l'acne ou de l'hyperseborrhee

Also Published As

Publication number Publication date
EP2283158A1 (en) 2011-02-16
US20110150774A1 (en) 2011-06-23
JP2011519572A (ja) 2011-07-14
WO2009135916A1 (en) 2009-11-12
RU2010150112A (ru) 2012-06-20
CA2723838A1 (en) 2009-11-12
MX2010011729A (es) 2011-04-05
FR2938342A1 (fr) 2010-05-14

Similar Documents

Publication Publication Date Title
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
SMT201600278B (it) Inibitori della benzossazolo chinasi e metodi d'uso
BRPI1012000A2 (pt) "sistema combustores e métodos de uso dos mesmos"
BRPI0910852A2 (pt) composições contendo lipídios e métodos de uso das mesmas
HRP20160859T1 (hr) Modificirani proteini rsv f i postupci njihove upotrebe
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI0808444A2 (pt) análogos de ciclopamina lactam e métodos de uso dos mesmos
BRPI0909077A2 (pt) Artigos multicamadas e métodos de preparo e uso dos mesmos
BRPI0821499A2 (pt) Artigos de filtração de fluído e métodos de preparo e uso dos mesmos
PT2129296E (pt) Dispositivo para medir as propriedades viscoelásticas de tecidos biológicos e procedimento utilizando este dispositivo
BR112012003661A2 (pt) "compostos de biarila e métodos de uso dos mesmos."
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
BRPI0715402A2 (pt) Marcadores de doença hepática gordurosa não alcoólica (nafld) e esteatohepatite não alcoólica (nash) e métodos de uso dos mesmos
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI0913726A2 (pt) rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
EP2079363A4 (en) SYSTEM AND METHOD FOR IN VIVO MEASUREMENT OF BIOLOGICAL PARAMETERS
BRPI0915959A2 (pt) silanos de éter fluorados e métodos de uso dos mesmos
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BR112012002855A2 (pt) "uso de um anticorpo anti-cd20 afucosilado e composição"
FR2937322B1 (fr) Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues
BRPI1014544A8 (pt) anticorpos anti-il-17f e metodos de uso dos mesmos
BRPI0914488A2 (pt) "composições de limpeza incluindo siloxanos de sorbitano modificados e uso das mesmas"
EP2291654A4 (en) PREPARATION AND COMPOSITION OF INTER ALPHA INHIBITOR PROTEINS FROM BLOOD
BRPI0907236A2 (pt) inibidores de proteína quinase e uso dos mesmos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2330 DE 01-09-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.